Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-89P is a pseudogene of the RNA, U1 small nuclear family, located on chromosome 4q28[2][3][4]. Unlike active protein-coding or functional non-coding RNA genes, RNU1-89P is classified as a pseudogene and is not believed to produce a functional transcript or participate in cellular processes such as splicing, as its canonical counterpart (e.g., RNU1-1) does[4]. There is insufficient evidence for RNU1-89P having a direct biological function, clinical disease role, or utility as a therapeutic target. Key context: RNU1-89P is not listed as an enzyme, receptor, transporter, or other commonly targeted biomolecule in drug development. There are no reports of drug interactions, clinical biomarker utility, or safety concerns related to targeting it. Its close relatives (such as RNU1-1/U1 snRNA) play critical roles in pre-mRNA splicing and transcript stability, but pseudogenes like RNU1-89P are generally considered nonfunctional genomic elements[4]. This entry should not be considered a therapeutic target, and requesting structured drug-target data for it will yield null or not applicable results. Notes on potential error: The designation "pseudogene" means it is not considered a functional molecular target, which makes it incorrect as a therapeutic or diagnostic target request[4]. This entry is correct as a genomic locus, but it is incorrect if interpreted as a functional drug target or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 89, pseudogene (RNU1-89P).